Can we predict how a patient will respond to a therapy - including novel ones not yet in the clinic? Doing so would improve personalized treatment and accelerate the discovery of new medicines but requires overcoming significant challenges. In this talk, I will cover Synthesize Bio's approach to the problem and how we are building virtual humans to model therapeutic outcomes